179 related articles for article (PubMed ID: 34293010)
1. Long-term effect of botulinum toxin A on the hip and spine in cerebral palsy: A national retrospective cohort study in Taiwan.
Lin CY; Chung CH; Matthews DJ; Chu HY; Chen LC; Yang SS; Chien WC
PLoS One; 2021; 16(7):e0255143. PubMed ID: 34293010
[TBL] [Abstract][Full Text] [Related]
2. The associated effects of untreated unilateral hip dislocation in cerebral palsy scoliosis.
Senaran H; Shah SA; Glutting JJ; Dabney KW; Miller F
J Pediatr Orthop; 2006; 26(6):769-72. PubMed ID: 17065943
[TBL] [Abstract][Full Text] [Related]
3. The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.
Willoughby K; Ang SG; Thomason P; Graham HK
Dev Med Child Neurol; 2012 Aug; 54(8):743-7. PubMed ID: 22686491
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and determinants of hip pain in non-ambulatory cerebral palsy children: a retrospective cohort study.
Faccioli S; Sassi S; Ferrari A; Corradini E; Toni F; Kaleci S; Lombardi F; Picelli A; Benedetti MG
Eur J Phys Rehabil Med; 2023 Feb; 59(1):32-41. PubMed ID: 36507793
[TBL] [Abstract][Full Text] [Related]
5. Effect of Botulinum Toxin Injection on the Progression of Hip Dislocation in Patients with Spastic Cerebral Palsy: A Pilot Study.
Lee Y; Lee S; Jang J; Lim J; Ryu JS
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941710
[TBL] [Abstract][Full Text] [Related]
6. Why the Hips Remain Stable When the Spine Strays: A Deeper Analysis of the Relationship Between Hip Displacement and Severe Scoliosis in Patients With Cerebral Palsy.
Hadad MJ; Xu AL; Bryant BR; Andrade NS; Hoon AH; Sponseller PD
J Pediatr Orthop; 2021 May-Jun 01; 41(5):261-266. PubMed ID: 33825716
[TBL] [Abstract][Full Text] [Related]
7. Primary surgery to prevent hip dislocation in children with cerebral palsy in Sweden: a minimum 5-year follow-up by the national surveillance program (CPUP).
Kiapekos N; Broström E; Hägglund G; Åstrand P
Acta Orthop; 2019 Oct; 90(5):495-500. PubMed ID: 31210072
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
[TBL] [Abstract][Full Text] [Related]
11. Proximal Femoral Varus Derotation Osteotomy in Children with Cerebral Palsy: The Effect of Age, Gross Motor Function Classification System Level, and Surgeon Volume on Surgical Success.
Shore BJ; Zurakowski D; Dufreny C; Powell D; Matheney TH; Snyder BD
J Bone Joint Surg Am; 2015 Dec; 97(24):2024-31. PubMed ID: 26677236
[TBL] [Abstract][Full Text] [Related]
12. The Long-term Outcome of Early Spine Fusion for Scoliosis in Children With Cerebral Palsy.
Sitoula P; Holmes L; Sees J; Rogers K; Dabney K; Miller F
Clin Spine Surg; 2016 Oct; 29(8):E406-12. PubMed ID: 25310392
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hip dislocation in severe cerebral palsy (GMFCS III-IV-V): an interdisciplinary and multi-professional Care Pathway for clinical best practice implementation.
Battisti N; Cozzaglio M; Faccioli S; Perazza S; Groppi A; Menta L; Motta M; Piovesan R; Digennaro GL; Rodocanachi M; Ronchetti AB; Sarno C; Saviola D; Valagussa G; Cersosimo A
Eur J Phys Rehabil Med; 2023 Dec; 59(6):714-723. PubMed ID: 37796120
[TBL] [Abstract][Full Text] [Related]
14. Comparison of botulinum toxin type A injection and soft-tissue surgery to treat hip subluxation in children with cerebral palsy.
Yang EJ; Rha DW; Kim HW; Park ES
Arch Phys Med Rehabil; 2008 Nov; 89(11):2108-13. PubMed ID: 18996239
[TBL] [Abstract][Full Text] [Related]
15. Radiological outcome of reconstructive hip surgery in children with gross motor function classification system IV and V cerebral palsy.
Zhang S; Wilson NC; Mackey AH; Stott NS
J Pediatr Orthop B; 2014 Sep; 23(5):430-4. PubMed ID: 24950105
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia.
Ameri A; Mirmohammadsadeghi A; Makateb A; Bazvand F; Hosseini S
Strabismus; 2015; 23(1):8-13. PubMed ID: 25789846
[TBL] [Abstract][Full Text] [Related]
18. Varus derotation osteotomy for the treatment of hip subluxation and dislocation in GMFCS level III to V patients with unilateral hip involvement. Follow-up at skeletal maturity.
Canavese F; Emara K; Sembrano JN; Bialik V; Aiona MD; Sussman MD
J Pediatr Orthop; 2010 Jun; 30(4):357-64. PubMed ID: 20502236
[TBL] [Abstract][Full Text] [Related]
19. Annual changes in radiographic indices of the spine in cerebral palsy patients.
Lee SY; Chung CY; Lee KM; Kwon SS; Cho KJ; Park MS
Eur Spine J; 2016 Mar; 25(3):679-86. PubMed ID: 25572149
[TBL] [Abstract][Full Text] [Related]
20. Factors Influencing Outcomes of the Dysplastic Hip in Nonambulatory Children With Cerebral Palsy.
Carroll KL; Stotts AK; Baird GO; Thorman AL; Talmage M; Moss WD; McMulkin ML; MacWilliams BA
J Pediatr Orthop; 2021 Apr; 41(4):221-226. PubMed ID: 33534371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
